Four days left to vote for the top nephrology story of 2013. So far, the top 3 are: The CORAL Trial The Nephron-D Trial JASN paper showing improved mortality for online HDF compared with standard HD. The first…
Genome-wide association studies (GWAS) are large population based collaborative studies seeking genetic patterns that would explain common complex phenotypes. These large studies have given us much insight into the genetic risk profile of patients with diseases such as…
Tacrolimus extended-release capsules were approved in the US by the Food and Drug Administration (FDA) in July 2013. The development of this new formulation garnered interest due to a possible improvement in immunosuppressive medication compliance. This formulation has…
Although I don’t believe that many will agree that this was the most important paper of the year in the world of nephrology, I do want to give a shout out to a paper published in JCI in…
In a year which gave us the bardoxolone failure, NEPHRON-D and the CORAL trial to name a few, a study with a positive result should be celebrated and the RAVE follow-up must be a contender for top 10…
Being a parent is probably one of the most desirable and difficult tasks in life. While ESRD is associated with a high rate of infertility related to hormonal changes and anovulation, most patients undergoing renal transplantation resume menstrual…
Despite a lack of strong evidence, angioplasty and stenting of atherosclerotic renal artery stenosis (RAS) became a common intervention in the last decade. It was often performed on incidental lesions discovered during “drive-by” angiography in cardiac procedures. In…
The JC virus is a member of the Polyomavirus family, which includes the BK virus. It infects about 80% of healthy adults and establishes latency in renal tissue. It was first isolated in 1971 from the brain of…
Organ donation from HIV positive patients has been prohibited in the USA since 1988. Pre-transplant screening for HIV is mandatory using nuclear amplification test (NAT), though false negative results during “window period” are a potential concern in donor…